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Summary
A calcifying fibrous tumor (CFT) is a benign tumor of unknown etiology. A calcifying fibrous tumor is rare in the in-
testinal tract. A calcifying fibrous tumor is characterized by hyalinized collagenous fibrous tissue, psammomatous or dys-
trophic calcification, and focal lymphoplasmacytic infiltrates on histology. Magnetic resonance imaging is the standard 
method for evaluating the lesions of the rectum, and CFTs should be considered in differentiating the rectal wall tumors. 
Herein, we report a case of a 68-year-old man with a rectal wall CFT.
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INTRODUCTION
A calcifying fibrous tumor (CFT) is a soft, 
rare benign tumor with unknown etiology. A CFT 
is characterized by the presence of a hyalinized 
collagenous fibrous tissue, psammomatous or 
dystrophic calcification, and focal lymphoplasma-
cytic infiltrate (1). CFT grows in the pleura, ex-
tremities, mediastinum, abdominal cavity, lungs, 
heart, mandible, neck, spine, back, inguinal and 
paratesticular area, and scrotum (2). CFT was first 
described in children (3) and rarely grows in the 
intestinal tract (4,5,6,7). Herein, we describe a case 
of a patient with a CFT in the rectal wall.
CASE REPORT
A 68-year-old man without any symptoms 
arrived for a routine check-up. Personal and fam-
ily history were unremarkable. The digital rectal 
exam found a mass on the front wall of the rectum 
with intact rectal mucosa. The laboratory values 
for leukocytes, erythrocytes, hemoglobin, hemato-
crit, and liver functions were within the normal 
range. The serum level of the carcinoembryonic 
antigen was also within the normal range. We per-
formed the colonoscopy with biopsy. A pathohis-
tological pattern of four pieces of tissue was not 
conclusive. The patient then underwent a mag-
netic resonance imaging (MRI) of the pelvis. Radi-
ologists used an MRI protocol with intravenous 
contrast and rectal distension with rectal gel ap-
plication. The MRI showed a mass in the lower 
third of the rectum’s front wall at a distance of 5 
cm from the anal verge. The mass was well-cir-
cumscribed, measuring 25x20x26mm. The tumor 
formation was low signal intensity on the T2-
weighted sequence (Fig. 1), intermediate signal 
intensity on the T1-weighted sequence (Fig. 2a). 
The tumor mass showed homogenous enhance-
ment after contrast application (Fig. 2b). On the 
diffusion-weighted imaging (DWI) sequences 
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Figure 1. T2-weighted axial (a) and sagittal (b) plane, low signal intensity mass in the rectal 
wall (shown by arrow)
Figure 2. T1-weighted (a), T1 THRIVE post-contrast axial plane image (b) showed homoge-
nous enhancement of the mass (shown by arrow)
Figure 3. Diffusion-weighted imaging (a) and apparent diffusion coefficient (b) showed the low 
signal intensity of mass (shown by arrow)
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(Fig. 3a) and apparent diffusion coefficient (ADC) 
mapping (Fig. 3b), the mass was low signal inten-
sity. The MRI examination suspected a fibrous tu-
mor. Based on the findings, the abdominal sur-
geon suggested the resection. After the operation, 
the pathology confirmed a calcifying fibrous tu-
mor - the rectal submucosal tumor consisted of fi-
brous tissue, collagenous tissue, inflammatory 
cells, and calcification psammoma bodies.
DISCUSSION
A calcifying fibrous tumor is a soft tissue tu-
mor, a rare and benign tumor of unknown etiolo-
gy. Rosenthal and Abdul Karim described the first 
cases of CFT as a fibrous tumor with psammoma 
bodies in two girls, two and eleven years old (3). 
The pathogenesis of the CFT is not clarified. Some 
studies connect the CFT to inflammatory myofi-
broblastic tumors (IMT), which suggests that CFT 
is the late IMT sclerosis phase (8). Some studies 
claim a CFT has a different immunohistochemical 
and histological appearance suggesting that the 
IMT and CFT are different lesions (9). The pres-
ence of a hypocellular, densely hyalinized colla-
gen with psammomatous or dystrophic calcifica-
tion, a proliferation of fibroblastic spindle cells, 
mononuclear inflammatory infiltrates, and lym-
phoid aggregates such as focal plasmocytes, neu-
trophils, eosinophils and mast cell infiltration 
characterize a histological CFT (2). Immunohisto-
chemical analysis is useful for the CFT diagnosis. 
Fibroblasts in the CFT do express factor XIIIa and 
vimentin, and they do not express S100, desmin, 
acetone, CD117, CD99, CD31, SMA, CD20, CD32, 
CD130, CD21, AE1 / AE3, EMA, estrogen receptor, 
callethrin, progesterone receptor, osteopontin, 
CAM5.2 and β-catanine (2). Chorti et al. analyzed 
157 cases of CFT in 104 articles and found that the 
mean age of patients was about 34 years, with a 
higher incidence in women than men (1.27: 1) and 
a mean tumor diameter was 4.6 cm (2). Im et al. 
published a case report of a patient with a rectal 
submucosal tumor and further analyzed six cases 
of CFTs in the digestive system. They reported 
that an intestinal CFT appears more often in men 
(66%), with smaller tumor diameter, and appears 
as a solitary lesion similar to our case (7).
Radiology differential diagnosis of the CFT 
in the digestive system includes the gastrointesti-
nal stromal tumor (GIST), desmoid, solitary fibro-
sis tumor (SFT), leiomyoma, schwannoma, and 
inflammatory myofibroblastic tumor (IMT).
Gastrointestinal stromal tumors present as 
solid masses, well-circumscribed, and may cause 
the narrowing of the lumen. Some lesions might 
have central necrosis. On MRIs, they tend to have 
low signal intensity on T1-weighted and high sig-
nal intensity on T2-weighted; the post-contrast en-
hancement is homogenous in the solid variety and 
the ring pattern in the case of a necrotic center 
(10). Large-sized lobulated contours increase in 
size on follow-up imaging, and the presence of he-
matogenous metastases are signs of malignancy; 
at the time of presentation, more than 50% of all 
GISTs have evidence of metastatic disease (10).
Desmoid tumors may manifest as a pelvic 
mass and may occur at any age. These tumors are 
not encapsulated with coarse white trabeculae 
that simulate scar tissue; at histologic analysis, 
desmoid tumors consist of elongated spindle-
shaped cells separated by dense collagen bands 
(11). These tumors are low signal intensity on T1-
weighted MR images and have a variable signal 
intensity on T2-weighted images (12).
A solitary fibrosis tumor is a mesenchymal 
tumor that appears mostly in the pleura, extreme-
ly rare in the pelvis, and usually occurs in the fifth 
decade. These tumors have intermediate signal 
intensity on T1-weighted images, and variable sig-
nal intensity on T2-weighted images shows that 
the low signal intensity on T2-weighted images 
suggests fibrous tissue and collagen stroma (13).
A leiomyoma is a rare tumor in the gastroin-
testinal tract. Tumors appear as a well-defined soft 
tissue intensity mass, the heterogeneous interme-
diate signal intensity with high signal intensity 
areas on T1-weighted sequences, and intermedi-
ate to high signal intensity on T2-weighted se-
quences (14). Schwannomas are peripheral nerve 
tumors arising from Schwann cells of the nerve 
sheath, rarely located in the pelvis. Schwannomas 
are considered to be benign tumors with the pos-
sibility of malignant transformation. On MRI, 
these tumors have homogeneous low signal inten-
sity on T1-weighted images and heterogeneous 
slight high signal intensity on T2-weighted imag-
es (15).
An inflammatory myofibroblastic tumor 
(IMT) is a very rare mesenchymal tumor, affecting 
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various organs, most frequently the lungs. An 
IMT is a spindle cell proliferation of disputed eti-
ology, with a distinctive fibroinflammatory and 
even pseudosarcomatous appearance. Tumors ap-
pear as a heterogeneous mass. The appearance is 
slightly low on MRIs on T1-weighted images and 
mixed intensity on T2-weighted images. En-
hanced-MRI shows an enhanced tumor (16). A 
DWI is routinely used in protocols for MRIs for 
the pelvis, allowing tissue characterization. High 
signal intensity on a DWI with simultaneous low 
signal intensity on ADC maps is usually associat-
ed with malignancy (17). A similar pattern is seen 
in some benign lesions. DWI findings must be cor-
related with standard T1-weighted and T2-
weighted images as well as with contrast-en-
hanced MRIs to avoid potential pitfalls. In our 
case, a low signal in DWIs and the low signal of 
ADC maps indicate that the tumor is a benign le-
sion, and the low signal in T2-weighted images 
further indicates a fibrous tissue and collagen 
stroma as a benign lesion. A proctoscopy with bi-
opsy is the most important method for diagnosing 
rectal tumors, but this procedure cannot deter-
mine the exact intramural extension of the tumor 
and cannot accurately differentiate submucosal 
and intramural tumors from extramural tumors. 
Transrectal ultrasound and MRI allow for evaluat-
ing the intestine wall thickness, which helps to 
characterize these tumors better. Recognizing 
these masses’ existence and their clinical and im-
aging features is crucial for clinicians to diagnose 
and adequately manage these conditions accu-
rately.
CONCLUSIONS
A calcifying fibrous tumor in the intestinal 
tract is very unusual and clinically unexpected. 
An MRI is a useful method for evaluating the rec-
tum wall process, and a CFT should be considered 
in the differential diagnosis of rectal submucosal 
tumors.
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KALCIFICIRANI FIBROZNI TUMOR REKTUMA: PRIKAZ SLUČAJA
T. Pavlović, R. Troskot Perić i S. Trtica
Kalcificirani fibrozni tumor (CFT) je benigni tumor nepoznate etiologije. CFT u crijevnom traktu je vrlo rijedak. CFT 
karakterizira prisutnost hijaliniziranog kolagenskog vlaknastog tkiva, psamomatoznih ili distrofičnih kalcifikacija i fokalnih 
limfoplazmocitnih infiltrata. Prikazujemo slučaj 68-godišnjeg muškaraca s CFT-om u stijenci rektuma. Magnetska rezonan-
cija je korisna metoda za procjenu procesa stijenke rektuma, CFT treba uzeti u obzir u diferencijalnoj dijagnozi tumorskih 
procesa stijenke rektuma.
KLJUČNE RIJEČI: magnetska rezonancija (MR), kalcificirajući fibrozni tumor, rektum




AI-Rad Companion linija proizvoda predstavlja komplet softvera u oblaku za naknadnu obradu snimki 
integracijom algoritama umjetne inteligencije. Ove su usluge namijenjene naknadnoj obradi 
primarnih snimki koje su generirali relevantni modaliteti. Rezultati koje generira AI-Rad Companion 
mogu se poslati unaprijed određenim sustavima koji imaju mogućnost zaprimanja DICOM objekata. 
Integrirani algoritmi temeljeni su na dubokom učenju i strojnom učenju.
AI-Rad Companion Organs RT je softver za 
naknadnu obradu koji automatski izrađuje 
konture DICOM CT slikovnih podataka uporabom 
algoritama temeljenih na dubokom učenju. 
Rezultati se generiraju kao konture u formatu 
DICOM RTSTRUCT objekata.
Softver AI-Rad Companion Organs RT osmišljen je 
kao klinički produžetak sustava AI-Rad Companion 
Engine kojemu se pristupa putem internetskog 
portala teamplay digital health platform.
Za pregled, uređivanje i prihvaćanje generiranih 
kontura, softver se mora upotrebljavati u 
kombinaciji s odgovarajućim softverima poput 
sustava za planiranje terapije i interaktivnih 
aplikacija za izradu obrisa.
Za svaku vrstu unesenih podataka, korisnici mogu 
odrediti zahtijevaju li rezultati ručnu potvrdu ili se 
automatski šalju sustavu za planiranje terapije 
(TPS).
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